naxagolide has been researched along with nicotine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carson, RE; Cosgrove, KP; Gallezot, JD; Huang, Y; Kloczynski, T; Labaree, D; Lim, K; Morris, ED; Pittman, B; Rabiner, EA; Ridler, K; Weinzimmer, D; Zheng, MQ | 1 |
Boileau, I; Di Ciano, P; Hendershot, CS; Houle, S; Lagzdins, D; Le Foll, B; Mansouri, E; Tyndale, RF; Wilson, AA | 1 |
2 other study(ies) available for naxagolide and nicotine
Article | Year |
---|---|
Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Macaca mulatta; Magnetic Resonance Imaging; Nicotine; Nicotinic Agonists; Oxazines; Positron-Emission Tomography; Protein Binding; Raclopride | 2014 |
Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers.
Topics: Adult; Brain; Carbon Isotopes; Cotinine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nicotine; Nicotinic Agonists; Oxazines; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Disorder | 2018 |